In the present study, a range of molecular tools were developed that will allow to close some 31 of the gaps in functional analysis of bifidobacteria. A number of promoters were tested for 32 transcriptional activity in B. bifidum S17 using pMDY23, a previously published promoter 33 probe vector. The promoter of the gap gene (P gap ) of B. bifidum S17 yielded the highest 34
Materials and Methods

123
Bacterial strains and growth conditions 124
The bacterial strains and plasmids used in this study are listed in supplementary Table S1 . 125
Bifidobacterium strains were cultured anaerobically in Lactobacilli MRS medium (Difco) 126 supplemented with 0.5 g l -1 L-cysteine (MRSc) at 37 °C. Anaerobic conditions were achieved 127 by cultivation using AnaeroGen sachets (Merck) in sealed jars. For cultivation of B. bifidum 128 S17 harbouring plasmids, the respective medium was supplemented with antibiotics at the 129 following concentrations: 1 µg ml -1 ampicillin, 5 µg ml -1 chloramphenicol, 2 µg ml -1 130 erythromycin, and 100 µg ml -1 spectinomycin unless stated otherwise. 131 E. coli DH10B was used as cloning host and was cultivated in 2× TY medium and grown to 132 stationary phase at 37 °C with agitation. For cultivation of strains harbouring plasmids, the 133 respective medium was supplemented with appropriate antibiotics (spectinomycin and 134 ampicillin: 100 µg ml -1 ; chloramphenicol: 15 µg ml -1 ; erythromycin: 300 µg ml -1 ). Sequence 135 integrity of all cloned inserts was verified by DNA sequencing (Eurofins MWG Operon, 136
Germany). Transformation into B. bifidum S17 was performed by electroporation as described 137 previously (19) . 138
139
Determination of selective antibiotic concentrations 140
Selective concentrations for ampicillin, chloramphenicol, erythromycin and spectinomycin 141
were determined for each of the Bifidobacterium sp. strains used in this study using a 142 microtiter plate assay. Fresh overnight (o/N) cultures were diluted in fresh MRSc containing 143 different concentrations of antibiotic to an OD 600 of 0.1 and distributed into individual wells 144 of a 96 well tissue culture plate (Sarstedt AG & Co., Newton, USA). As positive controls, 145
MRSc medium without antibiotics was inoculated to the same OD 600 . Plates were incubated 146 under anaerobic conditions for 24 h and growth was determined by measuring the OD 600 The glucuronidase assay was performed as described elsewhere (38) with minor 164 modifications. The assay is based on the enzymatic conversion of 4-methylumbelliferyl-β-D-165 glucuronide (MUG) to 4-methylumbelliferone (MU) by the β-glucuronidase GusA. MU is a 166 direct measure of GusA activity, which in turn correlates with promoter activity. GusA 167 activity was measured in cell free extracts of B. bifidum S17 harbouring pMDY23-derivatives 168 with different promoters cloned upstream of the gusA reporter gene (see supplementary 169
Materials and Methods). Recombinant strains were inoculated into 100 ml of MRSc at an 170 OD 600 of 0.1 from a fresh o/N culture and grown under anaerobic conditions at 37 °C. At the 171 indicated timepoints, bacteria were harvested by centrifugation (4 °C, 5,000× g, 10 min). 172
on September 23, 2017 by guest http://aem.asm.org/ Downloaded from 8 After washing with ddH 2 O and GUS assay buffer (50 mM Na 2 HPO 4 (pH 7), 1 mM EDTA, 173 0.1 % Triton X-100, 5 mM DTT), cells were resuspended in 1 ml GUS assay buffer and 174 disrupted in cryo-tubes with glass beads (0.1 mm diameter; Carl Roth) at 4 °C using a 175
RiboLyser (Hybaid) during three cycles of 30 seconds at full speed with cooling on ice for 1 176 min in between cycles. Lysates were centrifuged for 15 min at 14,000× g and 4 °C to remove 177 beads and bacterial debris. Supernatants were retained as cell free extracts and protein content 178 was measured in the supernatants using 2-D Quant kit (GE Healthcare Life Science). 179
GusA activity was measured in cell free extracts using 2.5 to 10 µg total protein in a final 180 volume of 100 µl in GUS assay buffer. Tübingen. Mice were bred and kept under specific pathogen free conditions at the animal 236 facility at the University of Ulm and were fed a standard laboratory chow and water ad 237 libitum. 238 C57BL/6J mice (both sexes, aged 7-12 weeks; n = 6) were inoculated with a single dose of 239
2×10
9 CFU of B. bifidum S17 pMGC-mCherry per animal. Faecal pellets were collected at 240 the indicated time points (0 -24 h after inoculation), weighed, and homogenised in 1 ml of 241 PBS by vigorous vortexing and used as faecal slurries for fluorescence microscopy. For 242 quantification of faecal carriage of B. bifidum S17 pMGC-mCherry, serial dilutions were 243 prepared and plated on MRSc agar plates containing 200 µg ml -1 mupirocin and 5 µg ml Furthermore, the synthetic promoters P hyper , P help and P CP25 were included, which were 278 previously shown to have high transcriptional activity in a number of Gram-positive bacteria 279 (45-47). These promoters were cloned upstream of the gusA reporter gene in pMDY23 280
( Figure 1A) , transformed into B. bifidum S17 and assayed for transcriptional activity by GusA 281 assay during growth of the recombinant strains ( Figure 1B) . No reporter activity could be 282 measured for P CP25 and P help . P gap showed consistently measurable transcriptional activity 283 except for the late stationary growth phase (i.e. after 24 h) and yielded the highest reporter 284 activities of all promoters at any time point assayed. GusA reporter activity could also be 285 measured for P pk and P hyper however at somewhat lower levels than P gap and not as 286 consistently throughout growth. Thus, P gap was considered an appropriate promoter for gene 287 expression in B. bifidum S17. 288 289
Expression of fluorescent proteins in bifidobacteria 290
In order to identify a bifidobacterial vector replicon with the widest possible host range, we 291 transformed a number of published E. coli/Bifidobacterium shuttle vectors including 292 pMDY23, pPKCm1, and pDG7 into various Bifidobacterium strains. Of these plasmids 293 pMDY23 had the broadest range of bifidobacterial hosts and was successfully and 294 reproducibly transformed into B. adolescentis NCC251, B. bifidum (strains S17 and S16), B. Table S2 ). The replicon of pMDY23 was thus chosen as the backbone 298 of all further plasmids generated in this study. 299
Based on pMDY23-P gap , a range of vectors for expression of different fluorescent proteins 300 was constructed. Four different plasmids were generated essentially by replacing the gusA 301 reporter gene in pMDY23-P gap with the genes for the fluorescent proteins CFP, GFP, YFP 302 and mCherry (Figure 2A ). Plasmids were constructed as described in the supplementary 303 Materials and Methods. This yielded plasmids pVG-CFP, pVG-GFP, pVG-YFP and pVG-304 mCherry, which were successfully transformed into three strains of bifidobacteria belonging 305 to three different species. Derivatives of B. bifidum S17 containing these different plasmids 306
showed high fluorescence at the expected wavelengths and virtually all bacteria were 307 fluorescent ( Figure 2B) . Moreover, the spectra of the emitted light were different enough to 308 distinguish differently labelled B. bifidum S17 strains in a mix ( Figure 2C Red fluorescent B. bifidum S17 pVG-mCherry adhering to Caco-2 cells could be visualised 316 by fluorescence microscopy ( Figure 3A) . In order to quantitatively assess adherent bacteria, a 317 calibration curve was established for B. bifidum S17 pVG-mCherry in the presence of Caco-2 318 cells. This revealed a high degree of correlation of fluorescence with CFU ( Figure 3B ). Using 319 this calibration curve, CFU of B. bifidum S17 pVG-mCherry were calculated based on 320 fluorescence measurements and compared to actual numbers of bacteria adhering to Caco-2 321 cells as determined by classical plate counting ( Figure 3C In a second approach, we sought to check if it is possible to image fluorescent bifidobacteria 325 inside relevant host cells. For this purpose, primary human macrophages were generated ex 326 vivo from monocytes by differentiation for 7 days in the presence of M-CSF and co-cultured 327 with B. bifidum S17 pVG-mCherry. Using fluorescence microscopy, high numbers of 328 intracellular B. bifidum S17 pVG-mCherry were detected (Figure 4) . 329
330
Plasmids for in vivo colonisation studies 331
Initial experiments on gastrointestinal colonisation and persistence of bifidobacteria revealed 332 that mice of the animal facility at the University of Ulm harbour an intrinsic B. animalis 333 strain, which was resistant to spectinomycin at 100 µg ml -1 , i.e. the concentration generally 334 used for selection of pMDY23 derivatives (data not shown). This prompted us to generate a 335 range of vectors for in vivo tracing studies. Based on pMDY23 four plasmids with different 336 antibiotic resistance genes and the pBluescript multiple cloning site were generated 337 (supplementary Materials and Methods and Figure S5A ). The selective concentrations to the 338 antibiotics used were tested for a range of bifidobacterial strains frequently used in our lab. 339
Using a 96-well microtiter plate assay, the concentrations that proved to be selective for 340 almost all strains tested were 1, 5, 2 and 100 µg ml -1 for ampicillin, chloramphenicol, 341 erythromycin, and spectinomycin, respectively (supplementary Table S6 ). However, B. 342 animalis subsp. animalis MB254 and B. animalis subsp. lactis NCC362 still showed minimal 343 growth at 100 µg ml -1 spectinomcyin. 344
These concentrations were successfully used to select clones of B. bifidum S17 harbouring 345 either pMGA, pMGC, pMGE or pMGS following electroporation. All plasmids were tested 346 for stability in B. bifidum S17 in the absence of antibiotic pressure. plasmid was successfully transformed into B. bifidum S17 yielding B. bifidum S17 pMGC-359 mCherry, which was then used to determine gastrointestinal transit time in mice. 360
For this purpose, female C57BL/6J mice (n = 6) were inoculated with B. bifidum S17 pMGC-361 mCherry by a single oral dose of 2×10 9 CFU per animal. Following inoculation, the numbers 362 of chloramphenicol-resistant bifidobacteria were enumerated in faecal pellets by plate-363 counting on selective agar ( Figure 5A ). This revealed that faecal shedding of B. bifidum S17 364 pMGC-mCherry peaked at around 5 h post inoculation when approx. 1×10 8 CFU g -1 faeces 365 were counted. Thereafter, counts continuously decreased until 24 h when for 4 out of 6 366 animals levels had dropped below the limit of detection, i.e. 1×10
3 CFU g -1 faeces. Moreover, 367
we were able to detect fluorescent B. bifidum S17 pMGC-mCherry in faecal slurries of 368 samples collected 5 h after inoculation ( Figure 5B analysed for transcriptional activity. No GusA reporter activity could be detected for the 376 synthetic promoters P CP25 and P help . This is somewhat surprising since both promoters were 377
shown to drive high levels of reporter gene expression in other Gram-positive and/or Gram-378 negative bacteria (45, 46, 48) and P help was successfully used to generate a luminescent B. 379 breve strain (22). P hyper was successfully used for recombinant protein expression in L. 380 monocytogenes (47, 49) . Similarly, reasonable transcriptional activity was observed for P hyper 381 in B. bifidum S17, however, only at early time points during growth. The promoter showing 382 highest levels of GusA reporter activity during the first 12 h of growth was P gap . This is in line 383 with the observation that the gap promoter is highly active in B. longum NCC2705 (41). 384
Consequently, the gap promoter of B. longum was successfully used for recombinant protein 385 expression (42, 43). However, the absence of reporter activity at later stages of growth, i.e. in 386 stationary phase, suggests that its use is limited to actively growing cultures. 387
The pMDY23 backbone was chosen for the generation of further plasmids based on 388 successful transformation into a total of 15 strains belonging to 7 different species with 4 389 subspecies (supplementary Table S2 and Refs 39, 50, 51). To our knowledge this represents 390 the widest range of bifidobacterial hosts for any E. coli/Bifidobacterium shuttle vector 391 described so far (2, 21, 52). 392
Using the P gap promoter and the backbone of pMDY23, a series of plasmids were constructed, 393 which allowed expression of four different FPs in B. bifidum S17, B. breve S27 and B. 394 longum E18. To the best of our knowledge, this represents the first report on the successful 395 
